Molly McGinniss
Molly McGinniss spoke at National Society of Genetic Counselors (NSGC) Annual Conference 2026 in November 2026 (speaker, “Rethinking Pediatric Screening in the Genomic Era ($)”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Molly. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Molly McGinniss, MS, CGC, is the co-founder of Alcance Genomics LLC, a genomics consulting company focused on accelerating the development and implementation of genomics programs, including the Shriners Children’s ShrineSeq Initiative. She is a board-certified genetic counselor with expertise in strategic planning, advisory board development, medical education, and evidence-generation strategy. Prior to co-founding Alcance Genomics, Molly led strategic advisory partnerships at Genome Medical, supporting healthcare organizations, laboratories, and industry partners in the development of genomics initiatives. Previously, she held global market development roles at Illumina focused on advancing adoption of genomic technologies in emerging clinical markets. Molly has held leadership roles within national genetics organizations, including serving as a two-term President of the Accreditation Council for Genetic Counseling (ACGC), an ex-officio member of the National Academies Roundtable on G
Sessions at 1 conference
National Society of Genetic Counselors (NSGC) Annual Conference 2026 10 November 2026 – 14 November 2026
- Rethinking Pediatric Screening in the Genomic Era ($) Speaker · 10 November 2026